Monosialoganglioside GM1 (GM1)

Monosialoganglioside GM1 is a sialic acid-containing glycosphingolipid predominantly located in the plasma membranes of neurons, where it clusters in lipid rafts. It functions as a critical modulator of transmembrane signaling, influencing the activity of various receptors and ion channels to maintain neuronal health and synaptic integrity (PubChem CID 6441487). GM1 is notably recognized as the primary cell surface receptor for the cholera toxin, facilitating its entry into intestinal cells (Wikipedia). In the context of neurodegeneration, GM1 levels are frequently reduced in conditions such as Parkinson's and Alzheimer's disease, leading to impaired neuroprotection and increased protein aggregation (PMC6521014). Therapeutic strategies have explored the administration of exogenous GM1 to slow disease progression, though concerns regarding the induction of autoimmune Guillain-Barré syndrome and limited central nervous system bioavailability remain significant challenges (StatPearls NBK557534). Additionally, genetic deficiencies in the enzymes responsible for GM1 degradation lead to GM1 gangliosidosis, a severe lysosomal storage disorder.

Other names

GM1 gangliosideMonosialotetrahexosylgangliosideGal-GalNAc-Gal(NeuAc)-Glc-CerII3Neu5Ac-Gg4Cer

Restoration of neuronal membrane composition, enhancement of neurotrophic factor signaling (e.g., BDNF/TrkB), stabilization of calcium homeostasis, and inhibition of alpha-synuclein aggregation (PMC6521014).